The tariff classification of Lamotrigine Tablets, Lamotrigine Chewable Dispersible Tablets, Mycophenolate Mofetil Capsules and Tablets in dosage form, from India
Reasoning
The tariff classification of Lamotrigine Tablets, Lamotrigine Chewable Dispersible Tablets, Mycophenolate Mofetil Capsules and Tablets in dosage form, from India
Cite this ruling
CBP Ruling N041656 (3004909130): The tariff classification of Lamotrigine Tablets, Lamotrigine Chewable Dispersible Tablets, Mycophenolate Mofetil Capsules and Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
Internal Advice Request; Classification of Chantix® (Varenicline) tablets for the treatment of nicotine dependency associated with smoking in adults
The tariff classification of FETZIMA Extended Release Capsules, imported in dosage form, from United States
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Metaxalone Tablets, imported in dosage form, from India
The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India